Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Masatoshi, Oka"'
Autor:
Seiji Hashimoto, Mitsuyo Itabashi, Kenta Taito, Ayano Izawa, Yui Ota, Takaaki Tsuchiya, Shiho Matsuno, Masahiro Arai, Noriko Yamanaka, Takako Saito, Masatoshi Oka, Noriyuki Suzuki, Yuki Tsuruta, Takashi Takei
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0301715 (2024)
IntroductionWe examined whether the Clinical Frailty Scale (CFS), a widely adopted tool for stratifying the degree of frailty, and the Dementia Assessment Sheet for Community-based Integrated Care System 21-items (DASC-21), a simple tool for simultan
Externí odkaz:
https://doaj.org/article/91d35498e6e04effbd3b01b13ee6c1ab
Autor:
Sumako Kameishi, Celia M. Dunn, Masatoshi Oka, Kyungsook Kim, Yun-Kyoung Cho, Sun U. Song, David W. Grainger, Teruo Okano
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Allogeneic “off-the-shelf” mesenchymal stem/stromal cell (MSC) therapy requires scalable, quality-controlled cell manufacturing and distribution systems to provide clinical-grade products using cryogenic cell banking. However, previous s
Externí odkaz:
https://doaj.org/article/e91a99820aa44a069683ec20c6c93603
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 545-553 (2020)
Abstract Aims/Introduction Adipose‐derived mesenchymal stem cell (ASC) transplantation is a promising therapy for diabetic nephropathy (DN). However, intravascular administration of ASCs is associated with low engraftment in target organs. Therefor
Externí odkaz:
https://doaj.org/article/122e65a5108c445b9e4e3bffc4299f29
Publikováno v:
Stem Cells Translational Medicine, Vol 8, Iss 12, Pp 1330-1341 (2019)
Abstract Renal fibrosis is one of the largest global health care problems, and microvascular (MV) injury is important in the development of progressive fibrosis. Although conventional cell therapy suppresses kidney injury via the role of vasoprotecti
Externí odkaz:
https://doaj.org/article/2694d0fd0b94409f9a0f40208818d081
Publikováno v:
Tissue Engineering Part C: Methods. 29:54-62
Autor:
Shiho, Matsuno, Mitsuyo, Itabashi, Akiko, Komatsu, Kenta, Taito, Ayano, Izawa, Takaaki, Tsuchiya, Noriko, Yamanaka, Masatoshi, Oka, Wako, Yumura, Tomio, Arai, Takashi, Takei
Publikováno v:
CEN Case Reports.
A 73-year-old Japanese woman, with a history of Sweet syndrome diagnosed 3 years earlier and anti-myeloperoxidase (MPO) antibody anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis diagnosed 1 year earlier, presented with an episode of
Autor:
Teruo Okano, Sophia Bou-Ghannam, Sumako Kameishi, Masatoshi Oka, David W. Grainger, Kyung Sook Kim
Publikováno v:
Journal of Controlled Release. 330:696-704
The evolution of drug discovery exploded in the early 20th century with the advent of critical scientific advancements in organic chemistry, chemical analysis, and purification. Early drug generations focused largely on symptom control and pain manag
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 545-553 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Adipose‐derived mesenchymal stem cell (ASC) transplantation is a promising therapy for diabetic nephropathy (DN). However, intravascular administration of ASCs is associated with low engraftment in target organs. Therefore, we con
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 8, Iss 12, Pp 1330-1341 (2019)
Stem Cells Translational Medicine, Vol 8, Iss 12, Pp 1330-1341 (2019)
Renal fibrosis is one of the largest global health care problems, and microvascular (MV) injury is important in the development of progressive fibrosis. Although conventional cell therapy suppresses kidney injury via the role of vasoprotective cytoki
Autor:
Naoko Sugiura, Sachiko Sekiya, Kosaku Nitta, Kazunori Karasawa, Yoei Miyabe, Masatoshi Oka, Tatsuya Shimizu, Takahito Moriyama
Publikováno v:
American journal of physiology. Renal physiology. 317(2)
Ischemia-reperfusion injury (IRI) is a clinically important cause of acute kidney injury leading to chronic kidney disease. Furthermore, IRI in renal transplantation still remains a risk factor for delayed graft function. Previous studies on IRI have